[SCHEDULE 13G] GeoVax Labs, Inc. Warrants SEC Filing

Rhea-AI Filing Summary

AZZ Inc. (AZZ) Form 4 filing discloses that Chief Financial Officer Jason Crawford acquired 305 shares of AZZ common stock on 30 June 2025 through the company’s 2018 Employee Stock Purchase Plan (ESPP). The purchase price was $69.63 per share, representing 85% of the stock’s closing price on the enrollment date, as stipulated by the ESPP. After the transaction, Crawford’s direct ownership increased to 13,031 shares. Transaction code J confirms the acquisition was made under an employee benefit plan and is exempt from Rule 16b-3(c).

• Insider role: Chief Financial Officer
• Form filed by one reporting person
• Ownership form: Direct
• No derivative securities were involved

The filing indicates modest incremental insider ownership rather than a discretionary open-market buy, providing a limited—but generally positive—signal of executive alignment with shareholders.

Positive

• CFO increased direct ownership, reinforcing alignment with shareholders.
• Purchase price reflects 15% discount achievable only through continued participation in the ESPP, indicating ongoing commitment to the program.

Negative

• Small transaction size (≈$21k) limits informational value for investors.
• Programmatic ESPP acquisition lacks the discretionary signal typically associated with open-market insider buys.

Insights

Equity Research Analyst

TL;DR: Small, routine ESPP purchase; mildly positive but not market-moving.

CFO Jason Crawford added 305 shares via the employee stock purchase plan, lifting his stake to 13,031 shares. Because the acquisition is programmatic (code J) at a preset 15% discount, it carries less signaling value than an open-market buy. The dollar value (~$21k) is immaterial relative to AZZ’s market cap, yet continuous ownership growth by a key executive supports alignment with shareholder interests. From a valuation perspective, the filing does not alter fundamentals or guidance; thus, trading impact should be minimal.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

GeoVax Labs, Inc.

(Name of Issuer)

Common stock, par value $0.001 per share

(Title of Class of Securities)

373678606

(CUSIP Number)

07/01/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 373678606

1

Names of Reporting Persons

Mitchell P. Kopin

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 2,792,404.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 2,792,404.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,792,404.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.99 %

12

Type of Reporting Person (See Instructions)

HC, IN

SCHEDULE 13G

CUSIP No. 373678606

1

Names of Reporting Persons

Daniel B. Asher

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 2,792,404.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 2,792,404.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,792,404.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.99 %

12

Type of Reporting Person (See Instructions)

HC, IN

SCHEDULE 13G

CUSIP No. 373678606

1

Names of Reporting Persons

Intracoastal Capital LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 2,792,404.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 2,792,404.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,792,404.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.99 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: GeoVax Labs, Inc.
(b)	Address of issuer's principal executive offices: 1900 Lake Park Drive, Suite 380, Smyrna, Georgia 30080
Item 2.
(a)	Name of person filing: This Schedule 13G is being filed on behalf of (i) Mitchell P. Kopin, an individual ("Mr. Kopin"), (ii) Daniel B. Asher, an individual ("Mr. Asher") and (iii) Intracoastal Capital LLC, a Delaware limited liability company ("Intracoastal" and together with Mr. Kopin and Mr. Asher, collectively the "Reporting Persons").
(b)	Address or principal business office or, if none, residence: The principal business office of Mr. Kopin and Intracoastal is 245 Palm Trail, Delray Beach, Florida 33483. The principal business office of Mr. Asher is 1011 Lake Street, Suite 311, Oak Park, Illinois 60301.
(c)	Citizenship: Mr. Kopin is a citizen of the United States of America. Mr. Asher is a citizen of the United States of America. Intracoastal is a Delaware limited liability company.
(d)	Title of class of securities: Common stock, par value $0.001 per share
(e)	CUSIP No.: 373678606
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: (i) Immediately following the execution of the Securities Purchase Agreement with the Issuer on July 1, 2025 (the "SPA") (as disclosed in the Form 8-K filed by the Issuer with the Securities and Exchange Commission on July 2, 2025), each of the Reporting Persons may have been deemed to have beneficial ownership of 1,767,433 shares of Common Stock, which consisted of (i) 1,515,000 shares of Common Stock to be issued to Intracoastal at the closing of the transaction contemplated by the SPA and (ii) 252,433 shares of Common Stock issuable upon exercise of a warrant to be issued to Intracoastal at the closing of the transaction contemplated by the SPA ("Intracoastal Warrant 1"), and all such shares of Common Stock represent beneficial ownership of approximately 9.99% of the Common Stock, based on (1) 15,924,593 shares of Common Stock outstanding as of June 30, 2025, as reported by the Issuer, plus (2) 1,515,000 shares of Common Stock to be issued to Intracoastal at the closing of the transaction contemplated by the SPA and (3) 252,433 shares of Common Stock issuable upon exercise of Intracoastal Warrant 1. The foregoing excludes (I) 2,777,567 shares of Common Stock issuable upon exercise of Intracoastal Warrant 1 because Intracoastal Warrant 1 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 1 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 9.99% of the Common Stock and (II) 4,466 shares of Common Stock issuable upon exercise of a warrant held by Intracoastal ("Intracoastal Warrant 2") because Intracoastal Warrant 2 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 2 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 4.99% of the Common Stock. Without such blocker provisions, each of the Reporting Persons may have been deemed to have beneficial ownership of 4,549,466 shares of Common Stock. (ii) As of the close of business on July 8, 2025, each of the Reporting Persons may have been deemed to have beneficial ownership of 2,792,404 shares of Common Stock issuable upon exercise of Intracoastal Warrant 1, and all such shares of Common Stock represent beneficial ownership of approximately 9.99% of the Common Stock, based on (1) 15,924,593 shares of Common Stock outstanding as of June 30, 2025, as reported by the Issuer, plus (2) 9,235,000 shares of Common Stock issued at the closing of the transaction contemplated by the SPA and (3) 2,792,404 shares of Common Stock issuable upon exercise of Intracoastal Warrant 1. The foregoing excludes (I) 237,596 shares of Common Stock issuable upon exercise of Intracoastal Warrant 1 because Intracoastal Warrant 1 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 1 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 9.99% of the Common Stock and (II) 4,466 shares of Common Stock issuable upon exercise of Intracoastal Warrant 2 because Intracoastal Warrant 2 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 2 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 4.99% of the Common Stock. Without such blocker provisions, each of the Reporting Persons may have been deemed to have beneficial ownership of 3,034,466 shares of Common Stock.
(b)	Percent of class: 9.99%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 2,792,404
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 2,792,404
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Mitchell P. Kopin

Signature:	/s/ Mitchell P. Kopin
Name/Title:	Mitchell P. Kopin
Date:	07/08/2025

Daniel B. Asher

Signature:	/s/ Daniel B. Asher
Name/Title:	Daniel B. Asher
Date:	07/08/2025

Intracoastal Capital LLC

Signature:	/s/ Mitchell P. Kopin
Name/Title:	Mitchell P. Kopin, Manager
Date:	07/08/2025

Exhibit Information

Exhibit 1 - Joint Filing Agreement

FAQ

How many AZZ shares did the CFO purchase?

Jason Crawford acquired 305 shares on 30 June 2025.

At what price were the shares bought?

The ESPP purchase price was $69.63 per share, equal to 85% of the closing price on the enrollment date.

What is the CFO's total AZZ shareholding after the transaction?

Following the purchase, Crawford directly owns 13,031 AZZ shares.

Was this an open-market purchase?

No. The acquisition occurred under the AZZ 2018 Employee Stock Purchase Plan (transaction code J).

Does this Form 4 filing suggest major strategic changes at AZZ?

The filing reports a routine ESPP purchase and does not indicate any strategic changes or new guidance.